Rossari Biotech Ltd share price logo

Rossari Biotech Share Price (ROSSARI)

Check the latest share price of Rossari Biotech, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹678.050.25%

as on 04:01PM, 13 Jun 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Rossari Biotech Stock Performance

Get live Rossari Biotech share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹667.1
    Day's Price Range
    ₹684.95
  • 52 Week's Low

    52 Week's High

    ₹569
    52-Week Price Range
    ₹972.7
1 Month Return-3.18 %
3 Month Return+ 11.96 %
1 Year Return-11.86 %
3 Year Return-19.89 %
5 Year Return-8.58 %
Previous Close₹679.75
Open₹676.00
Volume35.59K
Upper Circuit₹815.70
Lower Circuit₹543.80

Rossari Biotech Fundamentals & Key Indicators

Check Rossari Biotech market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹3,754.13 Cr

Return on Equity (ROE)

11.26

PE Ratio (TTM)

27.5

Return on capital employed (ROCE)

15.21

Industry PE ratio

59.41

Beta (LTM)

0.71

P/B Ratio

3.88

Dividend Yield

0.07

PEG Ratio

28.06

Quarterly Earnings Growth YOY

0.91

EPS (TTM)

24.63

Sector

Chemicals

Book Value

214.12

Technical Analysis

How to invest in Rossari Biotech?

Investing in Rossari Biotech is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Rossari Biotech or ROSSARI on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Rossari Biotech or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Rossari Biotech with just a few clicks!

Rossari Biotech Stock's Interest Amongst Investors

24%

Period Jun 15, 2025 to May 16, 2025. Change in 30 Days vs previous period

Search interest for Rossari Biotech Ltd Stock has increased by 24% in the last 30 days, reflecting an upward trend in search activity.

Rossari Biotech Valuation

Track how Rossari Biotech P/E has moved over time to understand its valuation trends.

Rossari Biotech in the last 5 years

  • Overview

  • Trends

Lowest (24.17x)

February 28, 2025

Today (27.50x)

June 13, 2025

Industry (59.41x)

June 13, 2025

Highest (90.67x)

September 15, 2021

LowHigh

Today’s Price to Earnings Ratio: 27.50x

Rossari Biotech Stock Recommendation

Get updated buy, sell, and hold recommendations by analysts on Rossari Biotech.

based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

100% of analysts recommend a 'BUY' rating for Rossari Biotech. Average target price of ₹850.5

Source: S&P Global Market Intelligence

Rossari Biotech Share Price Target

Get share price movements and forecasts by analysts on Rossari Biotech.

Rossari Biotech price forecast by 4 analysts

Upside of25.43%

High

₹1000

Target

₹850.50

Low

₹740

Rossari Biotech target price ₹850.5, a slight upside of 25.43% compared to current price of ₹678.05. According to 4 analysts rating.

Source: S&P Global Market Intelligence

Rossari Biotech Financial Results

Get the annual and quarterly financial summary of Rossari Biotech, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

473 (0%)490 (4%)498 (2%)513 (3%)580 (13%)
Net Income

(in ₹ Cr)

34 (0%)35 (2%)35 (1%)32 (10%)34 (9%)
Net Profit Margin7.22% (0%)7.13% (1%)7.09% (1%)6.18% (13%)5.94% (4%)
Value in ₹ crore
DetailsFY22FY23FY24FY25
Total Assets

(in ₹ Cr)

926 (0%)1126 (22%)1281 (14%)1455 (14%)
Total Liabilities

(in ₹ Cr)

141 (0%)267 (89%)321 (20%)378 (18%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

56 (0%)52 (7%)33 (36%)113 (241%)74 (35%)

Indices Featuring Rossari Biotech Stock

Check stock indices that include Rossari Biotech.

S&P BSE Commodities

₹7,619.99

-0.58 (-44.22%)

BSE Small-Cap

₹53,370.29

-0.3 (-161.18%)

Rossari Biotech Earnings and Dividends

View detailed summary of the earnings and dividend history of Rossari Biotech.

  • Rossari Biotech Ltd Earnings Results

    Rossari Biotech Ltd’s net profit jumped 0.91% since last year same period to ₹34.44Cr in the Q4 2024-2025. On a quarterly growth basis, Rossari Biotech Ltd has generated 8.64% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Rossari Biotech Ltd Dividends April,2024

    In the quarter ending March 2024, Rossari Biotech Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.15%.

    Read More about Dividends

Rossari Biotech Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Rossari Biotech.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
68.18%
0.00
Foreign Institutions
3.98%
0.00
Mutual Funds
13.29%
0.00
Retail Investors
10.25%
0.00
Others
4.3%
0.00

Rossari Biotech vs Peers

Compare market cap, revenue, PE, and other key metrics of Rossari Biotech with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY3,754.13-1.72%0.531362,080
NA7,876.0246.92%0.564847,929
BUY15,251.38158.27%0.744916,419
NA9,392.6396.14%0.75951,752
SELL6,070.354.82%0.531642,603

Rossari Biotech News & Key Events

Latest news and events in one place to help you make informed investing decisions in Rossari Biotech.

  • Rossari Biotech Aims for Revenue Growth and Expansion - 30 Apr, 2025

    Rossari Biotech targets a revenue growth of 10–15% in FY26, focusing on exports and capacity expansion. The company maintains a strong financial position with low net debt.
  • Rossari Biotech Reports Strong FY25 Financial Results - 27 Apr, 2025

    Rossari Biotech Limited announced robust financial results for FY 2025, with a total income of Rs. 20,002.94 million and a net profit of Rs. 1,851.85 million, indicating strong growth and market positioning.
  • Rossari Biotech Reports Modest Profit Growth - 26 Apr, 2025

    Rossari Biotech's consolidated net profit increased by 0.91% to Rs 34.44 crore for Q4 FY2025, with sales rising 22.60% to Rs 579.56 crore. For the full year, net profit grew 4.35% to Rs 136.38 crore, and sales increased 13.64% to Rs 2080.29 crore.
  • Rossari Biotech Expands Capacity for Competitive Edge - 25 Apr, 2025

    Rossari Biotech Ltd has approved capacity expansions for its subsidiaries, Unitop Chemicals and Tristar Intermediates, with a total investment of Rs 97 crore. This strategic move aims to enhance production capabilities and align with market demand forecasts.
  • Rossari Biotech Maintains Growth Outlook Amid US Demand - 08 Apr, 2025

    Rossari Biotech expects to boost exports to the US, currently at 2% of total sales. The company maintains its growth guidance of 12-13% for the current year and anticipates 10-12% growth for FY26, citing improving demand and positive sentiment from US customers.

Insights on Rossari Biotech Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 6 quarters, 467.29 Cr → 581.5 Cr (in ₹), with an average increase of 4.2% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 3.74% to 3.98% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 31.7 Cr → 34.44 Cr (in ₹), with an average increase of 8.0% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 13.25% to 13.29% in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, PCBL Chemical Ltd has given 299.9% return, outperforming this stock by 319.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, PCBL Chemical Ltd has given 61.6% return, outperforming this stock by 73.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, ROSSARI stock has moved down by -19.9%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 68.19% to 68.18% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 10.60% to 10.25% in Mar 2025 quarter

About Rossari Biotech

Rossari Biotech Limited, founded in 2003 as a partnership firm, is engaged in the manufacture, sale and distribution of specialty chemicals. It has two state-of-the-art facilities in Dahej in Gujarat and Silvassa in Dadra Nagar Haveli. It caters to global FMCG brands and its applications are used in consumer and home care products, textiles, animal health and nutrition and cosmetics. In FY 2020, the Company subdivided 5 million equity shares to 25 million equity shares and allotted 2.6 million equity shares to eligible members of the Company. It also issued 2.35 million equity shares to qualified institutional buyers on a preferential basis. During Q2 FY2021, IPOs of 11.7 million equity shares were issued with 10.5 million allotted to selling shareholders and 1.17 million to the fresh issue at a premium of Rs.423. During FY 2021, 3012046 equity shares were issued to the eligible members on a preferential basis whileUnitop Chemicals Private Limited, Tristar Intermediates Private Limited and Romakk Chemicals Private Limited were acquired by the Company. Solar panel was installed at Dahej facility to accommodate 1 MW solar power installation in FY 2022 which helped to save energy by 50 KVA. During 202122 several product developments have been made for the sizing of polyester and cotton fabric and the development of green products to reduce high TDS. Significant cross-selling opportunities have also been unlocked with the strategic investments made.

Revenue: ₹579.56Cr as on March 2025 (Q4 FY25)
Net Profit: ₹34.44Cr as on March 2025 (Q4 FY25)
Listing date: 23 Jul, 2020
Chairperson Name: Edward Menezes
OrganisationRossari Biotech Ltd
HeadquartersMumbai
IndustryChemicals
CEOEdward Menezes
E-voting on sharesClick here to vote

Mutual Funds that own Rossari Biotech

Check out the Mutual Funds with significant holdings in Rossari Biotech.

FAQs

What is Rossari Biotech share price today?

Rossari Biotech share price today stands at ₹678.05, Open: ₹676, Previous Close: ₹679.75, High: ₹684.95, Low: ₹667.1, 52 Week High: ₹972.7, 52 Week Low: ₹569.

What is today's traded volume of Rossari Biotech?

Today's traded volume of Rossari Biotech is 35.59K. Which means that 35.59K shares of Rossari Biotech were bought and sold on the stock market during today's trading session.

What is Rossari Biotech's market cap today?

Today's market capitalisation of Rossari Biotech is ₹3,754.13 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Rossari Biotech?

Rossari Biotech’s 52 week high is ₹972.7 and 52 week low is ₹569. The current share price of Rossari Biotech is ₹678.05, which is -30.29% down from its 52 week high and 19.17% up from its 52 week low.